Welcome to watch Ioannis Parodis interview to Lupus Hub on the 14th European Lupus. Dr. Ioannis Parodis discusses the emergence of approved targeted therapies, such as belimumab, anifrolumab, and the…
Check out the article entitled "Predictors of renal flares in systemic lupus erythematosus: a post-hoc analysis of four phase III clinical trials of belimumab" in Rheumatology.
Check out the article entitled "Reframing health disparities in SLE: A critical reassessment of racial and ethnic differences in lupus disease outcomes" in Best Practice & Research Clinical Rheumatology.
Check out our new article entitled "Serum profiling identifies CCL8, CXCL13, and IL-1RA as markers of active disease in patients with systemic lupus erythematosus" in Frontiers in Immunology.
Listen to the podcast about the latest advances on SLE and SSc focused on non-pharmacological management: common and disease-specific interventions patient education and self-management adjunct and not replace pharmaceutical treatment…
The 4th Annual Meeting of 3TR partners was held in Stockholm on 4-5 October 2023, hosted by Ioannis Parodis and Sven-Erik Dahlén. To be hosted on their beautiful premises during…
Recent Comments